In this interview, Greg Smith, CEO of IP Group, speaks to Dan Ridsdale, managing director, technology, at Edison Group, about the company’s H1 results, including a 3.2% rise in NAV per share to 114p and nearly £67m of realisations. They discuss progress towards IP Group’s £250m realisations target by 2027 and the de-risking of its exposure to Pfizer’s anti-obesity programme. They also cover developments across the portfolio, including Oxford Nanopore, Enterprise Therapeutics, Hysata and Oxa as well as IP Group’s investments in quantum computing and future compute, the expansion of its third-party capital platform and its approach to capital allocation.

**************************************************************************************

About ‘Bull, Bear & Beyond’

Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

281. Bull, Bear & Beyond – IP Group: executive interview

In this interview, Kooth CEO Kate Newhouse and CFO Sanjay Jawa discuss the company’s H1 financial performance, US growth opportunities and UK expansion. Kate discusses how the Meta settlement funding could help Kooth convert its US pipeline, and notes that negotiations on the California contract renewal, due next July, are on track. She also highlights the early traction from the UK Soluna launch, where registrations are almost double last year’s level two weeks after launch, and UK policy tailwinds, including the focus on young people not in education, employment or training. Sanjay covers the H1 financials, highlighting improved gross margin, a doubling of EBITDA, a return to profit after tax and a strong cash position. He also outlines the company’s capital allocation priorities, including US business development, international expansion, M&A and a possible return of capital.

**************************************************************************************

About ‘Bull, Bear & Beyond’

Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

280. Bull, Bear & Beyond – Kooth: executive interview

In this interview, Shepherd Neame’s CEO, Jonathan Neame, and CFO, Mark Rider, discuss the company’s FY26 results, the outlook for trading and the key priorities for investors. Topics include its ongoing pub refurbishment programme, the strategic review of the Brewing and Brands division in response to declining beer volumes and rising logistics costs, and the impact of consumer confidence and wider economic conditions on trading. They also explore the outlook for cost inflation, the company’s pricing power, the potential benefits of government policy changes and the implications of the forthcoming leadership transition, with Jonathan becoming executive chair and Mark taking on the role of managing director.

**************************************************************************************

About ‘Bull, Bear & Beyond’

Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

279. Bull, Bear & Beyond – Shepherd Neame: executive interview

In this interview, we speak with founder and CEO Hartley Atkinson of AFT Pharmaceuticals about the company’s growth ambitions and the opportunities ahead. Hartley discusses the continued global roll-out of Maxigesic, now sold in c 87 countries, and the significant potential of its intravenous formulation and further line extensions. He also highlights AFT’s capital-light business model and its portfolio of eight patented R&D projects, including a promising novel injectable iron formulation. Looking ahead, new product launches, R&D milestones and an emerging US commercial presence are important catalysts for AFT’s next phase of growth. From its flagship Maxigesic franchise to an expanding pipeline of proprietary medicines, AFT Pharmaceuticals is building a global growth story underpinned by innovation and international expansion.

**************************************************************************************

About ‘Bull, Bear & Beyond’

Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

278. Bull, Bear & Beyond – AFT Pharmaceuticals: executive interview

In this interview, we talk with Charlie Steel, CFO of International Workplace Group (IWG), the world’s largest flexible workspace provider. Charlie provides a brief overview of the group, its strategy and the market that it operates in, before discussing the outlook for growth in earnings and cash flow. Business demand for IWG’s offering is driven by the need for flexible, well-located office space, while landlords are attracted by the opportunity to fill buildings and increase income on their assets. These complementary trends are driving rapid growth in IWG’s increasingly capital-light network, and we discuss the cash flow and shareholder returns that this is generating. The company recently reiterated its guidance for $585–625m of EBITDA in 2026, up from $531m in 2025, and returned $144m in share buybacks and dividends. Over the medium term, it targets EBITDA of around $1bn and 50% free cash flow conversion. We end the conversation by considering the potential for successful delivery on strategy and growth to deliver not just strong shareholder cash returns but a re-rating of the company’s shares.

**************************************************************************************

About ‘Bull, Bear & Beyond’

Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

277. Bull, Bear & Beyond – International Workplace Group: executive interview

In our latest interview with the senior management team of Global Fashion Group, Leandro Medeiros, the CEO of Dafiti, discusses the strategic priorities shaping the future of one of Latin America’s leading fashion e-commerce businesses. The conversation explores how Dafiti is strengthening its technology platform to support greater scale and operating efficiency, where the company sees its key sources of future growth and how it is seeking to sustain differentiation in a highly competitive market. Leandro also discusses Dafiti’s priorities for 2026, the areas where AI could move from experimentation to providing a measurable business impact and how changing consumer behaviour may reshape the Latin American fashion e-commerce market over the next two to three years.

**************************************************************************************

About ‘Bull, Bear & Beyond’

Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

276. Bull, Bear & Beyond – Dafiti: executive interview

In this interview, Kenneth MacKenzie, CEO of Target Fund Managers, talks about the recently released annual report from Target Healthcare REIT and the outlook. The year to June 2026 (FY26) was very successful, and the c 12% accounting total return (the change in NAV per share plus dividends paid) was the strongest since Target was founded 13 years ago. But Target invests for the long term and perhaps more impressive is the consistency of performance, reflected in an average 7.8% annual return since launch. Kenneth believes there is much more growth ahead for the company, underpinned by its unwavering focus on asset quality in a sector with strong, long-term demographic tailwinds. Target’s portfolio of modern, high-quality, fully ESG-compliant homes is appealing to operators and residents alike, underpinning long leases, inflation-linked rental uplifts and income sustainability. With a strong pipeline of acquisition opportunities and capital recycling to keep the portfolio refreshed, Kenneth provides a confident outlook.

**************************************************************************************

About ‘Bull, Bear & Beyond’

Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

275. Bull, Bear & Beyond – Target Healthcare REIT: executive interview

In this interview, we speak with OSE Immunotherapeutics CEO Marc Le Bozec and chairman Markus Cappel. We discuss the company’s progress since announcing its strategic plan for 2026–28. In particular, we focus on OSE’s lead immunology and inflammation asset, lusvertikimab, including its track record in the clinic for ulcerative colitis, development of the subcutaneous formulation and plans for a new Phase II trial in chronic pouchitis. An update is also provided for Tedopi, the lead immuno-oncology asset. The interview concludes with a summary of key catalysts and milestones investors should watch for in the next 12–18 months.

**************************************************************************************

About ‘Bull, Bear & Beyond’

Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

274. Bull, Bear & Beyond – OSE Immunotherapeutics: executive interview

In this interview, we speak with Mateusz Nowak, chief commercial officer and board member of Noctiluca, who discusses the company's progress towards commercialising NCEIL-4, its advanced material for organic light-emitting diode (OLED) displays. The lead programme has moved from proof-of-concept towards proof-of-performance, with Noctiluca increasing production 100-fold and raising material purity from 99.6% to 99.95%. Independent testing within the lead customer's supply chain has demonstrated significant improvements in OLED lifetime, while validation has broadened to four applications across a pipeline of 15 partners. Management expects mass-production-line testing during Q426, formal qualification in late Q426/Q127 and, subject to successful customer audits, repeatable commercial deliveries during H227. Nowak also discusses investment in physical vapour deposition (PVD) equipment and manufacturing capacity in Poland, intended to accelerate future product development, together with grant and institutional funding designed to finance the company's transition towards commercial-scale supply.

**************************************************************************************

About ‘Bull, Bear & Beyond’

Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

273. Bull, Bear & Beyond – Noctiluca: executive interview

US investors traded $217bn of non-US equities in Q2 alone – up 37% year-on-year – as concerns over a concentrated, AI-heavy S&P 500 push them towards value and quality overseas. In this episode of Vantage, we sit down with Jonathan Dickson, head of EMEA at OTC Markets, to find out why household names from Roche and Heineken to Tesco and the London Stock Exchange Group trade there, how companies are winning serious US investor attention without the cost and complexity of a Nasdaq listing, and what smaller issuers need to get right to be found by American money. Watch now to see how your company could tap into one of the fastest-growing pools of capital in the world.

**************************************************************************************

About ‘Bull, Bear & Beyond’

Bull, Bear & Beyond': features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

About Edison:

Edison is a content-led IR business. We believe quality investment content should inform all investors, not just brokers. Our mission: engage and build bigger, better-informed investor audiences for our clients.

Edison covers 50+ investment trusts, read about them here: https://www.edisongroup.com/equities/investment-companies/

272. Bull, Bear & Beyond – Vantage: US investors are pouring billions into non-US stocks – is your company on their radar?

'Uncovering Trusts': Edison analysts interview investment trusts to uncover how they maximize returns while managing risk for clients. 

Discover fresh perspectives in the Bull, Bear & Beyond podcast series by Edison Group. Our longer episodes feature candid conversations with senior executives and from our own team of experts from acr

Bull, Bear & Beyond by Edison Group · Zencastr

Bull, Bear & Beyond by Edison Group

Discover fresh perspectives in the Bull, Bear & Beyond podcast series by Edison Group. Our longer episodes feature candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation and the opportunities shaping their markets. These discussions offer unique insight into how leaders navigate challenges, drive growth and deliver long-term value for stakeholders. Our 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

To find out more, please visit: https://www.edisongroup.com/ [https://www.edisongroup.com/equities/investment-companies/]